Population
38 patients with synovial sarcoma diagnosed and treated from 1976 to 1994, including 4 with metastatic…
Design
Case_series
Follow-up
minimum 4-year followup for all surviving patients
Authors
Loading...
Tumor size may inform risk stratification in localized synovial sarcoma; this Level 5 finding leaves open neoadjuvant chemotherapy trials for tumors >10 cm.
Tumor size is a strong prognostic factor for survival in localized synovial sarcoma, with tumors >10 cm having only 20% survival, prompting the need for neoadjuvant chemotherapy trials in this subgroup.
Thompson et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: